Company / Total Assets
Veracyte, Inc. Total Assets History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Assets
$1.4B
FY2025
5-year range
$1.1B / $1.4B
FY2021-FY2025
Trend
+8.2%
vs FY2024
Sector context
#107 of 166
Health Care
What the data says
At $1.4B, Veracyte, Inc.'s total assets ranks #107 of 166 in the Health Care sector. Total Assets has fluctuated over the past 10 years, ranging from $79M in FY2017 to $1.4B in FY2025.
Based on SEC 10-K filings.
$1.4B in FY2025 with a 5-year CAGR of +25.2%.
Improved from $1.1B to $1.4B over the past 2 years.
Health Care sector context is included.
Total Assets over time
Growth rates
- 3-Year CAGR
- +6.7%
- 5-Year CAGR
- +25.2%
- 10-Year CAGR
- -
Sector benchmark
#107 of 166 in Health CareTop 64% of 166This company $1.4B Sector average $15.0B
▼
-90.6% below sector average
Key checks
Key Insights
- 5-year CAGR of +25.2%, indicating consistent growth.
- In FY2025, total assets increased 8.2% year-over-year.
- Ranks #107 out of 166 companies in the Health Care sector.
- Lowest total assets in the period was in FY2017.
Company context
Key Data Points
- Altman Z-Score 6.19 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.4B | +8.2% |
| FY2024 | $1.3B | +16.6% |
| FY2023 | $1.1B | -3.6% |
| FY2022 | $1.2B | -2.6% |
| FY2021 | $1.2B | +159.8% |
| FY2020 | $457.2M | +66.1% |
| FY2019 | $275.2M | +128.1% |
| FY2018 | $120.6M | +53.3% |
| FY2017 | $78.7M | -22.1% |
| FY2016 | $101.0M | +34.3% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026